174 related articles for article (PubMed ID: 19695099)
1. Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy.
Magne J; Dubois M; Champagne J; Dumesnil JG; Pibarot P; Philippon F; O'Hara G; Sénéchal M
Cardiovasc Ultrasound; 2009 Aug; 7():39. PubMed ID: 19695099
[TBL] [Abstract][Full Text] [Related]
2. Clinical Usefulness of N-terminal Prohormone of Brain Natriuretic Peptide and High Sensitivity Troponin T in Patients with Heart Failure Undergoing Cardiac Resynchronization Therapy.
Debska-Kozlowska A; Ksiazczyk M; Warchol I; Lubinski A
Curr Pharm Des; 2019; 25(14):1671-1678. PubMed ID: 31223080
[TBL] [Abstract][Full Text] [Related]
3. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
[TBL] [Abstract][Full Text] [Related]
4. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
[TBL] [Abstract][Full Text] [Related]
5. Clinical, echocardiographic, and neurohormonal response to cardiac resynchronization therapy: are they interchangeable?
Hoogslag GE; Höke U; Thijssen J; Auger D; Marsan NA; Wolterbeek R; Holman ER; Schalij MJ; Bax JJ; Verwey HF; Delgado V
Pacing Clin Electrophysiol; 2013 Nov; 36(11):1391-401. PubMed ID: 23826659
[TBL] [Abstract][Full Text] [Related]
6. Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure.
Yu CM; Fung JW; Zhang Q; Chan CK; Chan I; Chan YS; Kong SL; Sanderson JE; Lam CW
J Card Fail; 2005 Jun; 11(5 Suppl):S42-6. PubMed ID: 15948100
[TBL] [Abstract][Full Text] [Related]
7. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
Fruhwald FM; Fahrleitner-Pammer A; Berger R; Leyva F; Freemantle N; Erdmann E; Gras D; Kappenberger L; Tavazzi L; Daubert JC; Cleland JG
Eur Heart J; 2007 Jul; 28(13):1592-7. PubMed ID: 17298973
[TBL] [Abstract][Full Text] [Related]
8. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
9. Impact of cardiac resynchronization therapy on inflammatory biomarkers and cardiac remodeling: The paradox of functional and echocardiographic response.
Almeida-Morais L; Abreu A; Oliveira M; Silva Cunha P; Rodrigues I; Portugal G; Rio P; Soares R; Mota Carmo M; Cruz Ferreira R
Rev Port Cardiol (Engl Ed); 2018 Feb; 37(2):105-113. PubMed ID: 29503051
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of N-terminal pro-B-type natriuretic peptide increase with exercise for predicting cardiovascular mortality in patients with heart failure.
Koç M; Bozkurt A; Acartürk E; Sahin DY; Unal I
Am J Cardiol; 2008 Apr; 101(8):1157-62. PubMed ID: 18394451
[TBL] [Abstract][Full Text] [Related]
11. Role of Right Ventricular Dysfunction and Diabetes Mellitus in N-terminal pro-B-type Natriuretic Peptide Response of Patients With Severe Mitral Regurgitation and Heart Failure After MitraClip.
Kaneko H; Neuss M; Weissenborn J; Butter C
Int Heart J; 2017 Apr; 58(2):225-231. PubMed ID: 28216549
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy.
Lellouche N; De Diego C; Cesario DA; Vaseghi M; Horowitz BN; Mahajan A; Wiener I; Boyle NG; Fonarow GC; Shivkumar K
Am J Cardiol; 2007 Jan; 99(2):242-6. PubMed ID: 17223426
[TBL] [Abstract][Full Text] [Related]
14. Cardiorenal status using amino-terminal pro-brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: From the BIOCRT Study.
Truong QA; Szymonifka J; Januzzi JL; Contractor JH; Deaño RC; Chatterjee NA; Singh JP
Heart Rhythm; 2019 Jun; 16(6):928-935. PubMed ID: 30590191
[TBL] [Abstract][Full Text] [Related]
15. Body composition in heart failure and the impact of cardiac resynchronisation therapy: a proof-of-concept study.
McAloon CJ; Hyndman S; Ansell V; O'Hare P; Randeva H; Osman F
Open Heart; 2020; 7(1):e001105. PubMed ID: 32153788
[TBL] [Abstract][Full Text] [Related]
16. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation.
Yusoff R; Clayton N; Keevil B; Morris J; Ray S
Am J Cardiol; 2006 May; 97(10):1498-501. PubMed ID: 16679092
[TBL] [Abstract][Full Text] [Related]
17. Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score.
Bakos Z; Chatterjee NC; Reitan C; Singh JP; Borgquist R
BMC Cardiovasc Disord; 2018 Apr; 18(1):70. PubMed ID: 29699498
[TBL] [Abstract][Full Text] [Related]
18. Cardiac resynchronization therapy--clinical and echocardiographic characteristics of responders and exceptional responders.
Galrinho A; Branco LM; Oliveira MM; Da Silva N; Abreu J; Santos S; Leal A; Ferreira RC
Rev Port Cardiol; 2009 Sep; 28(9):959-69. PubMed ID: 19998807
[TBL] [Abstract][Full Text] [Related]
19. Quantification of ventricular resynchronization reserve by radionuclide phase analysis in heart failure patients: a prospective long-term study.
Dauphin R; Nonin E; Bontemps L; Vincent M; Pinel A; Bonijoly S; Barborier D; Ribier A; Fernandes CM; Bert-Marcaz P; Itti R; Chevalier P
Circ Cardiovasc Imaging; 2011 Mar; 4(2):114-21. PubMed ID: 21239562
[TBL] [Abstract][Full Text] [Related]
20. Clinical and echocardiographic correlates of improvement in left ventricular diastolic function after cardiac resynchronization therapy.
Aksoy H; Okutucu S; Kaya EB; Deveci OS; Evranos B; Aytemir K; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
Europace; 2010 Sep; 12(9):1256-61. PubMed ID: 20478931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
